Jerel A BanksÂ
Non-Executive Director
Pharmaceutical sciences
Benitec Biopharma
Australia
Biography
Jerel has been a director since October 25, 2016. Dr. Banks is the Chief Investment Officer of Nant Capital, LLC. Prior to joining Nant Capital, LLC, Dr. Banks served as vice president, portfolio manager and research analyst for the Franklin Biotechnology Discovery Fund at Franklin Templeton Investments from 2012 to 2015. During his time as portfolio manager and research analyst the assets under management for the Franklin Biotechnology Discovery Fund reached $5 Billion (USD). Prior to his tenure at Franklin Templeton Investments, he worked as a biotechnology equity research analyst at Sectoral Asset Management from 2011-2012. Sectoral Asset Management, a healthcare-focused global investment management company, managed a family of investment portfolios with total assets under management of $3 Billion (USD). From 2008-2011, Jerel worked as a biotechnology equity research analyst at Apothecary Capital, the healthcare investment management team for the family investment office of the Bass Family of Fort Worth, Texas.
Research Interest
Pharmaceutical sciences
